Contineum Therapeutics Inc

CTNMNASDAQ · USD
13.53USD0.00 (+2.43%)
259

Contineum Therapeutics Inc (CTNM) Option Chain

As of September 18, 2026, Contineum Therapeutics Inc is trading at $13.53, a +2.43% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 132.0%. IV Rank is 19%.

Read more

Tracking the CTNM option chain helps you see every strike and expiry on Contineum Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Contineum Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CTNM options activity at a glance. Use our scanner to monitor the CTNM option chain in real time and filter for the CTNM options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CTNM stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the CTNM option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where CTNM stock options are being actively traded and where they are not.

Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. Its lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and progressive multiple sclerosis (MS). The company also develops PIPE-307, a novel, small molecule selective inhibitor of the muscarinic type 1 M1 receptor to treat depression and relapse remitting MS; and CTX-343, a peripherally-restricted LPA1R antagonist.

Contineum Therapeutics, Inc. was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. The company was incorporated in 2009 and is headquartered in San Diego, California.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Contineum Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen CTNM options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of CTNM stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile19.44% Subdued
  • Market cap (M$)509
  • 52 weeks high-23.90%
  • 52 weeks low57.33%
  • Analyst recommendationStrong Buy
    1.38
  • Target price$22.43
    65.78% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-10-29
  • P/E
  • Future P/E
  • EPS (ttm)-1.74
  • EPS growth next 5 years4.67%

As of September 18, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
7.14000.076.034.008.207.50-44.571.800.001.8005592.86
25.23000.123.531.505.8010.00-26.094.100.004.100274.77
48.09201.471.030.104.9012.50-7.614.700.004.700151.91
67.66204.600.004.6015.00+10.860.504.901.471.230132.34
81.22300.750.000.7517.50+29.342.506.503.970.530018.78

As of September 18, 2026

Scan the full option chain in one place

Browse the full CTNM option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial